Quality of life in cancer patients treated by chemotherapy

Many studies connected with different aspects of the quality of life (QL) h ave been increasingly reported. In this study we have been used FACT questi onnaire to estimate QL in three groups of cancer patients receiving chemoth erapy. Questionnaires were completed by 177 patients. Adverse effects of tr eatment severely influence the cancer patients QL. The mast significant wor sening of QL was noticed in the group of lung cancer patients receiving the most emetogenic chemotherapy (i.e. cis-platinum, vepesid). In other two gr oups (gastric and colorectal cancer patients) side effects of chemotherapy caused relatively less QL deterioration. This finding implicates possibilit y of intensifying the course of treatment (dosage and duration) assuming th ere is no hematopoetic insufficiency.